| Analysis | Metabolite Name | Measured Value | Units | Feeding:Fed | Group |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 438909 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 534095 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 558127 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 596636 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 629151 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 646079 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 659856 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 671955 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 688783 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 696038 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 712455 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 731204 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 737077 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 741269 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 757364 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 762731 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 784045 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 792029 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 809442 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 816373 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 818210 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 888008 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 890545 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 898109 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 911028 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 912883 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 919962 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 920210 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 934609 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 959866 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 960422 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 973941 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1002189 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1004551 | Peak area | HCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1028421 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1031343 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1038594 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1042627 | Peak area | HCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1105541 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1117604 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1136814 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1179632 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1197515 | Peak area | LCR-AL |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1256000 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1302335 | Peak area | LCR-CR |
| Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2403036 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 49628 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 50217 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 50382 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 50788 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 53064 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 55494 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 57475 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 61835 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 63869 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 65063 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 65160 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 66203 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 69770 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 74770 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 76869 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 80625 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 83514 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 87348 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 89332 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 91285 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 93366 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 97401 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 101196 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 104189 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 106642 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 115991 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 120656 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 131262 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 134052 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 134669 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 134969 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 146677 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 149653 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 161223 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 162143 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 744100 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 846354 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 855019 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 869813 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 898895 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 900063 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 997092 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | Peak area | LCR-CR | |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 2417 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 2512 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 2641 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 3401 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 3978 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 4009 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 4015 | Peak area | LCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 4158 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 4294 | Peak area | HCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 6433 | Peak area | HCR-AL |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 59640 | Peak area | LCR-CR |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | HCR-AL | |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | HCR-CR | |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | LCR-AL | |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | LCR-CR | |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | HCR-AL | |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | HCR-CR | |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | LCR-AL | |
| Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | LCR-CR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|